Oruka Therapeutics (ORKA) Other Working Capital Changes (2010 - 2026)

Oruka Therapeutics' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$461000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 411.49% year-over-year to -$461000.0; the TTM figure through Mar 2026 stood at $3.4 million (up 812.5% YoY), while the FY2025 annual figure was $4.0 million, up 28471.43% from the prior year.
• Other Working Capital Changes was -$461000.0 for Q1 2026 at Oruka Therapeutics, down from $805000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $2.4 million in Q3 2025 to a low of -$2.0 million in Q4 2024.
• Historically, Other Working Capital Changes has averaged $152705.9 across 5 years, with a median of -$200000.0 in 2023.
• Biggest YoY gain for Other Working Capital Changes was 1088.0% in 2024; the steepest drop was 737.82% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at -$357000.0 in 2022, then surged by 33.33% to -$238000.0 in 2023, then plunged by 737.82% to -$2.0 million in 2024, then surged by 140.37% to $805000.0 in 2025, then slumped by 157.27% to -$461000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$461000.0 (Q1 2026), $805000.0 (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.